Kezar Life Sciences Inc (KZR)
7.55
+0.01
(+0.13%)
USD |
NASDAQ |
Nov 14, 16:00
7.55
0.00 (0.00%)
After-Hours: 20:00
Kezar Life Sciences Enterprise Value: -98.97M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | -98.97M |
| November 12, 2024 | -99.34M |
| November 11, 2024 | -99.70M |
| November 08, 2024 | -100.21M |
| November 07, 2024 | -99.92M |
| November 06, 2024 | -99.77M |
| November 05, 2024 | -100.72M |
| November 04, 2024 | -102.25M |
| November 01, 2024 | -101.38M |
| October 31, 2024 | -99.63M |
| October 30, 2024 | -94.23M |
| October 29, 2024 | -99.23M |
| October 28, 2024 | -97.62M |
| October 25, 2024 | -96.66M |
| October 24, 2024 | -95.48M |
| October 23, 2024 | -95.40M |
| October 22, 2024 | -97.07M |
| October 21, 2024 | -96.18M |
| October 18, 2024 | -93.88M |
| October 17, 2024 | -94.45M |
| October 16, 2024 | -88.70M |
| October 15, 2024 | -90.51M |
| October 14, 2024 | -90.51M |
| October 11, 2024 | -92.14M |
| October 10, 2024 | -91.70M |
| Date | Value |
|---|---|
| October 09, 2024 | -90.92M |
| October 08, 2024 | -99.99M |
| October 07, 2024 | -97.51M |
| October 04, 2024 | -95.80M |
| October 03, 2024 | -93.75M |
| October 02, 2024 | -93.43M |
| October 01, 2024 | -96.29M |
| September 30, 2024 | -97.57M |
| September 27, 2024 | -114.30M |
| September 26, 2024 | -115.42M |
| September 25, 2024 | -113.93M |
| September 24, 2024 | -113.71M |
| September 23, 2024 | -112.64M |
| September 20, 2024 | -112.35M |
| September 19, 2024 | -111.48M |
| September 18, 2024 | -111.93M |
| September 17, 2024 | -112.03M |
| September 16, 2024 | -112.18M |
| September 13, 2024 | -112.40M |
| September 12, 2024 | -112.61M |
| September 11, 2024 | -111.81M |
| September 10, 2024 | -113.13M |
| September 09, 2024 | -112.59M |
| September 06, 2024 | -113.16M |
| September 05, 2024 | -111.67M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-156.05M
Minimum
Nov 10 2023
840.82M
Maximum
Mar 24 2022
106.00M
Average
93.84M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.762M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 6.814M |
| Theriva Biologics Inc | -13.26M |
| Oragenics Inc | 2.142M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.55M |
| Total Expenses (Quarterly) | 21.90M |
| EPS Diluted (Quarterly) | -3.00 |
| Earnings Yield | -180.1% |